Summit Therapeutics Inc (SMMT)

Oct 31, 2025

Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

Should you hold or exit Summit Therapeutics Inc. now2025 Volume Leaders & High Conviction Investment Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Summit (NASDAQ: SMMT) at SITC 2025: HARMONi-A; first Phase III OS benefit for ivonescimab - Stock Titan

Oct 31, 2025

Oct 31, 2025

1 Monster Stock in the Making to Buy and Hold - AOL.com

Oct 31, 2025

Oct 31, 2025

What institutional flow reveals about Summit Therapeutics Inc.Day Trade & Free Community Consensus Stock Picks - newser.com

Oct 31, 2025

Oct 31, 2025

Can Summit Therapeutics Inc. hit a new high this monthDollar Strength & Short-Term Trading Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Applying sector rotation models to Summit Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025

Oct 30, 2025

Jefferies Cuts Summit Therapeutics (SMMT) Price Target, Keeps Buy Rating - Insider Monkey

Oct 30, 2025

Oct 30, 2025

Summit Therapeutics (SMMT) Releases Financial Results and Updates on Operational Progress for Q3 2025 - Insider Monkey

Oct 30, 2025

Oct 30, 2025

Summit Therapeutics Inc.Common Stock (NQ: SMMT - FinancialContent

Oct 30, 2025

Oct 30, 2025

Summit Therapeutics (SMMT) Aims for FDA Nod for Ivonescimab in N - GuruFocus

Oct 30, 2025

Oct 30, 2025

Summit Therapeutics (SMMT) files for 26.68M share offering by selling stockholders - StreetInsider

Oct 30, 2025

Oct 30, 2025

News impact scoring models applied to Summit Therapeutics Inc.Quarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com

Oct 30, 2025

Oct 30, 2025

Is Summit Therapeutics Inc. showing signs of accumulation2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - newser.com

Oct 30, 2025

Oct 30, 2025

Is Summit Therapeutics Inc. stock reversal real or fake2025 Trading Recap & Daily Stock Trend Reports - newser.com

Oct 30, 2025

Oct 29, 2025

Why Wall Street Is Backing These 3 Comeback Stocks - Investing.com

Oct 29, 2025

Oct 29, 2025

Patterns Watch: Is Summit Therapeutics Inc. stock a safe haven asset2025 Volume Leaders & Weekly High Return Stock Forecasts - Fundação Cultural do Pará

Oct 29, 2025

Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Picks Up 2.5% More Stock - simplywall.st

Oct 28, 2025

Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Robert Duggan Buys 2.5% More Shares - Yahoo Finance

Oct 28, 2025

Oct 28, 2025

Insider Spends US$262m Buying More Shares In Summit Therapeutics - 富途牛牛

Oct 28, 2025

Oct 28, 2025

Can Summit Therapeutics Inc. stock outperform in 2025 bull marketEarnings Overview Summary & Real-Time Volume Analysis Alerts - Fundação Cultural do Pará

Oct 28, 2025

Oct 28, 2025

Analyzing Summit Therapeutics Inc. with risk reward ratio charts2025 Price Targets & High Return Stock Watch Alerts - newser.com

Oct 28, 2025

Oct 28, 2025

Allianz Asset Management GmbH Decreases Stock Holdings in Summit Therapeutics PLC $SMMT - MarketBeat

Oct 28, 2025

Oct 28, 2025

What margin trends mean for Summit Therapeutics Inc. stock2025 Top Decliners & Fast Exit/Entry Strategy Plans - Fundação Cultural do Pará

Oct 28, 2025

Oct 27, 2025

Summit Therapeutics proves InvestingPro’s Fair Value accuracy with 40% return By Investing.com - Investing.com South Africa

Oct 27, 2025

Oct 26, 2025

Summit Therapeutics' (SMMT) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 26, 2025